Study finds genetically modified rice good source of vitamin A for malnourished children

NewsGuard 100/100 Score

"Genetically modified rice could be a good source of vitamin A for children in countries where deficiency in the vitamin is common," according to a new study published in the American Journal of Clinical Nutrition, Reuters reports. "The study tested so-called Golden Rice against both spinach and supplements in providing vitamin A to 68 six- to eight-year-olds in China," the news service notes. "Researchers found that the rice was as effective as the capsules in giving kids a boost of vitamin A, based on blood tests taken over three weeks," and that "it worked better than the natural beta-carotene in spinach," according to Reuters. "The product has been around for years, but it has yet to come into real-world use for a number of reasons," the news service notes, adding, "Because it's genetically modified, it has faced opposition from environmental groups and others." Reuters writes, "There have also been questions about how efficiently the beta-carotene in Golden Rice can be converted into vitamin A, especially in children" (Norton, 8/15).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Vosoritide's first phase 2 study shows increased growth in children with hypochondroplasia